Time: 5:40

‘A match made…

Industry has had to change its approach to innovation as the world becomes more inter-connected, according to Seema Kumar, Vice President, Innovation, Global Health, and Policy Communication, Johnson & Johnson. Kumar spoke to BiotechDispatch in advance of giving a keynote address on…

Read More...
‘A match made in heaven’
Industry has had to change its approach to innovation as the world becomes more inter-connected,…

AusBiotech’s Asian investment…

Australian life science companies presented to local life science investors in Asia earlier this month, as part of AusBiotech’s high-profile investment series. The Asian investment series attracted over 200 investors and 30 life science companies and signified a valuable opportunity…

Read More...
AusBiotech’s Asian investment series strengthens interest in…
Australian life science companies presented to local life science investors in Asia earlier this month,…

Recruitment milestone for…

Immuron (ASX:IMC) has announced that its IMM-124E Phase 2 clinical trial for the treatment of NASH (Non-Alcoholic Steatohepatitis) has reached its 50 per cent recruitment milestone with 56 patients having been successfully randomised and an additional 4 patients to be randomised…

Read More...
Recruitment milestone for Immuron NASH study
Immuron (ASX:IMC) has announced that its IMM-124E Phase 2 clinical trial for the treatment of NASH…

Latest News

26 May 2016Latest News

LBT will ‘continue to grow and prosper,’ says retiring CEO

Retiring CEO of LBT Innovations (ASX:LBT), Lusia Guthrie, has delivered an upbeat message in her final note to shareholders. “Although this will…

26 May 2016Interview

‘A match made in heaven’

Industry has had to change its approach to innovation as…

26 May 2016AusBiotech

AusBiotech’s Asian investment series strengthens interest in…

Australian life science companies presented to local life science investors…

26 May 2016Latest News

Type 1 diabetes innovation awards

The Juvenile Diabetes Research Foundation has announced that the Australian Type 1 Diabetes Clinical Research Network Innovation Awards are open for applications.…

26 May 2016Latest News

Curve secures spot in MAP Startup Accelerator

Digital health company Curve Tomorrow has been awarded a place…

26 May 2016Latest News

Recruitment milestone for Immuron NASH study

Immuron (ASX:IMC) has announced that its IMM-124E Phase 2 clinical trial…

24 May 2016Policy

Greens back support for collaborations and commercialisation

The Greens would direct significant additional investment towards supporting commercialisation…

24 May 2016Company News

Biotron compounds record activity against Zika

A significant boost for Biotron (ASX:BIT) after the Sydney-based company reported positive results from tests involving two compounds targeting Zika…

24 May 2016Company News

Clarity Pharmaceuticals completes $2m capital raise

Clarity Pharmaceuticals, an emerging Australian biotech company specialising in the…